Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital

Qi Wang, Xiaotao Zhao, Zhihong Yue, Xiaohui Bai, Huiying Rao, Na Han, Tianbing Wang, Hui Wang & Baoguo Jiang
Under the ongoing COVID-19 prevention and control measures in China, increasing the laboratory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid testing capacity has become the top priority. Since the COVID-19 outbreak in Xinfadi market in Beijing in June 2020, large-scale screening of key populations has been carried out, challenging the nucleic acid testing capabilities of hospital laboratories. Therefore, within 48 hours, Peking University People’s Hospital (PKUPH) transformed a non-nucleic acid testing laboratory into...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.